Polyvinylpyrrolidone-loaded Zn and ZnO nanoparticles influence Escherichia coli isolated from urinary tract infection patients
DOI:
https://doi.org/10.60988/p.v37i2S.238Keywords:
Escherichia coli; urinary tract infections; Zn-NP; ZnO-NP; phoAAbstract
The biofilm formed by Escherichia coli contributes to pathogenesis through the intercellular contact within the biofilm, thereby facilitating bacterial proliferation and infection. This underscores the need for alternative antimicrobial agents with enhanced efficacy compared to traditional antibiotics. In this study, urinary tract infection (UTI)-derived E. coli isolates were assessed for susceptibility to zinc (Zn) and zinc oxide (ZnO) nanoparticles stabilised with the use of polyvinylpyrrolidone. Thirty isolates were treated with Zn and ZnO nanoparticles, and conventional polymerase chain reaction (PCR) was employed in order to detect the presence of virulence genes (phoA, VTL, and LT1). The phoA gene was detected in the majority of isolates, whereas the VTL and LT1 genes were not observed. Bacterial counts were higher in untreated controls than in nanoparticle-treated samples, with this difference being particularly pronounced in phoA-positive isolates. These findings suggest that Zn and ZnO nanoparticles hold therapeutic potential against UTI-causing E. coli strains.
References
1. Lin W.H., Zhang Y.Z., Liu P.Y., Chen P.S., Wang S., Kuo P.Y., et al. Distinct characteristics of Escherichia coli isolated from patients with urinary tract infections in a medical center at a ten-year interval. Pathogens 10(9), 1156, 2021. DOI: 10.3390/pathogens10091156
2. Poirel L., Madec J.Y., Lupo A., Schink A.K., Kieffer N., Nordmann P., et al. Antimicrobial resistance in Escherichia coli. Microbiol. Spectr. 6(4), arba-0026-2017, 2018. DOI: 10.1128/microbiolspec.ARBA-0026-2017
3. Bannov A.G., Popov M.V., Kurmashov P.B. Thermal analysis of carbon nanomaterials: advantages and problems of interpretation. J. Therm. Anal. Calorim. 142, 349–370, 2020. DOI: 10.1007/s10973-020-09647-2
4. Gundinger T., Kittler S., Kubicek S., Kopp J., Spadiut O. Recombinant protein production in E. coli using the phoA expression system. Fermentation 8(4), 181, 2022. DOI: 10.3390/fermentation8040181
5. Joffré E., Sjöling Å. The LT1 and LT2 variants of the enterotoxigenic Escherichia coli (ETEC) heat-labile toxin (LT) are associated with major ETEC lineages. Gut Microbes 7(1), 75–81, 2016. DOI: 10.1080/19490976.2015.1127480
6. Markoulatos P., Siafakas N., Moncany M. Multiplex polymerase chain reaction: a practical approach. J. Clin. Lab. Anal. 16(1), 47–51, 2002. DOI: 10.1002/jcla.2058
7. Rashid S.N., Aadim K.A., Jasim A.S. Silver nanoparticles synthesized by Nd: YAG laser ablation technique: characterization and antibacterial activity. Karbala Int. J. Mod. Sci. 8, 71–82, 2022. DOI: 10.33640/2405-609X.3210
8. Mohammed H.A., Sahi N.M., Ahmed R.T., Al-Rubaye A.F. Antimicrobial activity of some nanoparticles synthesized by laser ablation technique against some bacteria isolated from oral cavity. Med. J. Babylon 19(4), 601–608, 2022. DOI: 10.4103/MJBL.MJBL_147_22
9. Ismael N.M., Azzam M., Abdelmoteleb M., El-Shibiny A. Phage vB_Ec_ZCEC14 to treat antibiotic-resistant Escherichia coli isolated from urinary tract infections. Virol. J. 21(1), 44, 2024. DOI: 10.1186/s12985-024-02306-0
